|
40 Companies |
|
26 Products |
|
26 Products |
|
26 Mechanisms of Action |
|
1 Trial |
|
852 News |
|
| «12...6789101112131415161718» |
- | New P2 trial: Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (clinicaltrials.gov) - Apr 15, 2012
P2, N=24, Completed, Sponsor: EndoStim Inc.
- ||| Trial completion: The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients (clinicaltrials.gov) - Apr 15, 2012
P=N/A, N=1233, Completed, Sponsor: AstraZeneca
Recruiting --> Completed
- Clinical: Evolution of Swallowing in Patients Undergoing Lateral Pharyngoplasty With Preservation Stylopharyngeal Muscle (clinicaltrials.gov) - Apr 8, 2012
P=N/A, N=1, Completed, Sponsor: Hospital do Servidor Publico Estadual
- | New P1/2 trial: Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study (clinicaltrials.gov) - Apr 8, 2012
P1/2, N=100, Recruiting, Sponsor: Midwest Biomedical Research Foundation
- HEOR: Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease (clinicaltrials.gov) - Apr 4, 2012
P=N/A, N=384, Recruiting, Sponsor: Midwest Biomedical Research Foundation
- Trial withdrawal: A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux (clinicaltrials.gov) - Mar 28, 2012
P4, N=0, Withdrawn, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Completed Recruiting --> Withdrawn
- Enrollment change: A New Nasopharyngeal pH Probe for Diagnosis of Laryngopharyngeal Reflux (clinicaltrials.gov) - Mar 28, 2012
P4, N=0, Withdrawn, Sponsor: Children's Hospital of Philadelphia
Recruiting --> Withdrawn N=35 --> 0
- Clinical: Study of Tongue Strengthening for Swallowing Problems (clinicaltrials.gov) - Mar 26, 2012
P=N/A, N=100, Not yet recruiting, Sponsor: University of Wisconsin, Madison
- ||| Trial completion: A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) (clinicaltrials.gov) - Mar 25, 2012
P1, N=69, Completed, Sponsor: Janssen Research & Development, LLC
N=35 --> 0 Recruiting --> Completed
- Trial completion: rTMS AVC: Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia (clinicaltrials.gov) - Mar 21, 2012
P4, N=30, Completed, Sponsor: University Hospital, Rouen
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=100, Completed, Sponsor: AHS Cancer Control Alberta
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects (clinicaltrials.gov) - Mar 12, 2012
P1, N=30, Completed, Sponsor: Eisai Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Completed
- Enrollment open: Validity of a New Stroke Dysphagia Screening Tool (clinicaltrials.gov) - Mar 11, 2012
P=N/A, N=18, Recruiting, Sponsor: Rhode Island Hospital
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- New P3 trial: TAMEO: Peroral Endoscopic Myotomy for Primary Esophageal Achalasia (clinicaltrials.gov) - Mar 5, 2012
P3, N=16, Recruiting, Sponsor: Hospices Civils de Lyon
- | omeprazole / Generic mfg., fluoxetine / Generic mfg.
Trial completion: Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial (clinicaltrials.gov) - Mar 4, 2012
P2/3, N=144, Completed, Sponsor: Tehran University of Medical Sciences
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial initiation date: Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer (clinicaltrials.gov) - Feb 28, 2012
P2, N=150, Active, not recruiting, Sponsor: Radiation Therapy Oncology Group
Recruiting --> Completed Initiation date: Jan 2011 --> Feb 2012
- ||||| esomeprazole / Generic mfg.
New P2 trial: Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis (clinicaltrials.gov) - Feb 22, 2012
P2, N=150, Active, not recruiting, Sponsor: Yuhan Corporation
- esomeprazole / Generic mfg.
Enrollment change: Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=18, Completed, Sponsor: David A. Johnson, MD
Initiation date: Jan 2011 --> Feb 2012 N=25 --> 18
- | esomeprazole / Generic mfg.
Trial completion: Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=18, Completed, Sponsor: David A. Johnson, MD
N=25 --> 18 Recruiting --> Completed
- ||||||| Trial completion: Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) (clinicaltrials.gov) - Feb 12, 2012
P3, N=344, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting --> Completed Recruiting --> Completed
- | omeprazole / Generic mfg.
Trial completion: Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease (clinicaltrials.gov) - Feb 8, 2012
P3, N=195, Completed, Sponsor: Chang Gung Memorial Hospital
Recruiting --> Completed Recruiting --> Completed
- New P1/2 trial: Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders (clinicaltrials.gov) - Jan 31, 2012
P1/2, N=20, Recruiting, Sponsor: Chinese University of Hong Kong
- Trial completion, Intubation: Fibreoptic Intubation With and Without Sellick (clinicaltrials.gov) - Jan 28, 2012
P=N/A, N=50, Completed, Sponsor: Glostrup University Hospital, Copenhagen
Recruiting --> Completed Not yet recruiting --> Completed
- Trial initiation date: Post-operative Sore Throat as Determined by Endotracheal Tube Inflation Technique (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=141, Completed, Sponsor: University of California, San Francisco
Not yet recruiting --> Completed Initiation date: Mar 2011 --> Nov 2011
- Enrollment closed: A Pilot Study of Acupuncture Treatment for Dysphagia (clinicaltrials.gov) - Jan 17, 2012
P=N/A, N=42, Active, not recruiting, Sponsor: Dana-Farber Cancer Institute
Initiation date: Mar 2011 --> Nov 2011 Recruiting --> Active, not recruiting
- Trial withdrawal: DRNERD: Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD (clinicaltrials.gov) - Jan 16, 2012
P3, N=0, Withdrawn, Sponsor: Inje University
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- Enrollment change: DRNERD: Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD (clinicaltrials.gov) - Jan 16, 2012
P3, N=0, Withdrawn, Sponsor: Inje University
Not yet recruiting --> Withdrawn N=122 --> 0
- Trial completion: Evaluation of Swallowing in Patients With Obstructive Sleep Apnea (clinicaltrials.gov) - Jan 11, 2012
P=N/A, N=21, Completed, Sponsor: Luciana Almeida Moreira da Paz Oliveira
N=122 --> 0 Active, not recruiting --> Completed
- | Trial completion: Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease (clinicaltrials.gov) - Jan 5, 2012
P=N/A, N=40, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Recruiting --> Completed
- New P4 trial: Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft (clinicaltrials.gov) - Jan 3, 2012
P4, N=50, Recruiting, Sponsor: Oregon Health and Science University
- | Trial completion: Pharyngocise Dose Response Study (clinicaltrials.gov) - Jan 3, 2012
P2/3, N=130, Completed, Sponsor: University of Florida
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: ANSRS: Adjunctive Neuromuscular Electrical Stimulation for the Rehabilitation of Swallowing (clinicaltrials.gov) - Jan 3, 2012
P2/3, N=53, Completed, Sponsor: University of Florida
Recruiting --> Completed Active, not recruiting --> Completed
- remifentanil / Generic mfg.
New P4 trial: Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration (clinicaltrials.gov) - Dec 18, 2011
P4, N=25, Completed, Sponsor: University Hospital Orebro
- |||||||||| New P3 trial, Head-to-Head: Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease (clinicaltrials.gov) - Dec 13, 2011
P3, N=239, Completed, Sponsor: Norgine
- ||| esomeprazole / Generic mfg.
Trial completion: Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy (clinicaltrials.gov) - Dec 13, 2011
P=N/A, N=500, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired Adult (clinicaltrials.gov) - Dec 12, 2011
P=N/A, N=35, Not yet recruiting, Sponsor: Fraser Health
- amifostine / Generic mfg.
Trial termination: Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia (clinicaltrials.gov) - Dec 6, 2011
P2, N=42, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Terminated; funding became unavailable
- Trial completion: A Pilot Study of Pulmonary Function in Dysphagic Infants (clinicaltrials.gov) - Nov 28, 2011
P=N/A, N=26, Completed, Sponsor: University of Tennessee
Active, not recruiting --> Terminated; funding became unavailable Recruiting --> Completed
- Dexilant (dexlansoprazole) / Takeda
New P1/2 trial: Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis (clinicaltrials.gov) - Nov 21, 2011
P1/2, N=0, Withdrawn, Sponsor: Mayo Clinic
- | Trial completion: Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI (clinicaltrials.gov) - Nov 17, 2011
P2/3, N=236, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Completed
- || Takecab (vonoprazan) / Takeda, Phathom Pharma
New P3 trial: Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (clinicaltrials.gov) - Nov 16, 2011
P3, N=827, Completed, Sponsor: Takeda Pharmaceutical Company Limited
- Clinical: Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist (clinicaltrials.gov) - Nov 14, 2011
P=N/A, N=292, Completed, Sponsor: Helsinki University
- HEOR: Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer (clinicaltrials.gov) - Nov 13, 2011
P=N/A, N=100, Recruiting, Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- Trial completion: Swallowing Training in Parkinson`s Disease (clinicaltrials.gov) - Nov 6, 2011
P=N/A, N=17, Completed, Sponsor: Federal University of Bahia
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment closed, HEOR: Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia (clinicaltrials.gov) - Oct 31, 2011
P=N/A, N=90, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| esomeprazole / Generic mfg.
New P3 trial, Head-to-Head: Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC (clinicaltrials.gov) - Oct 30, 2011
P3, N=188, Not yet recruiting, Sponsor: Eurofarma Laboratorios S.A.
- | fluticasone / Generic mfg.
Trial completion: Topical Steroid Treatment for Eosinophilic Esophagitis (clinicaltrials.gov) - Oct 25, 2011
P2, N=42, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Enrollment change: Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia (clinicaltrials.gov) - Oct 11, 2011
P3, N=200, Completed, Sponsor: International Atomic Energy Agency
Active, not recruiting --> Completed N=420 --> 200
- | Trial completion: Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia (clinicaltrials.gov) - Oct 11, 2011
P3, N=200, Completed, Sponsor: International Atomic Energy Agency
N=420 --> 200 Recruiting --> Completed
- |||||||||| New P3 trial: Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux (clinicaltrials.gov) - Oct 10, 2011
P3, N=70, Recruiting, Sponsor: TTY Biopharm